Contact Us
Drug Search Results
More Filters [+]

Pidotimod

Alternative Names: pidotimod
Latest Update: 2024-04-12
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Immunostimulant

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: China | Colombia | Dominican Republic | Egypt | India | Italy | Korea | Mexico | Pakistan | Russia

Approved Indications: None

Known Adverse Events: None

Company: Almirall
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pidotimod

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Respiratory Tract Infections|Pneumonia|Healthy Volunteers|Urinary Tract Infections|Communicable Diseases

Phase 1: Otitis Media|Urinary Tract Infections|Respiratory Tract Infections|Bronchitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
P-CRESCENT

P4

Completed

Communicable Diseases|Respiratory Tract Infections

2021-11-04

ChiCTR2000038335

N/A

Completed

Respiratory Tract Infections

2020-12-31

CTR20200397

N/A

Completed

Respiratory Tract Infections|Urinary Tract Infections

2020-04-24

ChiCTR1900022404

N/A

Completed

Healthy Volunteers

2019-06-25

Recent News Events

Date

Type

Title

04/12/2024

PubMed

 Analysis of Factors and T-Lymphocyte Subset Changes in Pediatric Recurrent Respiratory Infections Post-Pidotimod Treatment.

02/01/2024

PubMed

 Investigation on the Efficacy of Two Food Supplements Containing a Fixed Combination of Selected Probiotics and β-Glucans or Elderberry Extract for the Immune System: Modulation on Cytokines Expression in Human THP-1 and PBMC.

08/05/2023

PubMed

 Application of immunomodulatory therapy in a human brucellosis patient with pancytopenia: A case report.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions